List of insiders holdings for SpringWorks Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
1 | GORDON CARL L Director 10% Owner | 2019-09-12 16:28:35 | 0 7,131,307 | 7,131,307 | Form 3 |
2 | SQUINTO STEPHEN P Director 10% Owner | 2022-05-20 17:44:52 | 146,970 6,186,307 | 6,333,277 | Form 4 |
3 | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner | 2023-12-06 16:43:33 | 3,567,159 0 | 3,567,159 | Form 13D |
4 | Schwartz Jeffrey Lawrence Director | 2023-05-25 17:04:48 | 24,346 3,081,307 | 3,105,653 | Form 4 |
5 | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner | 2023-03-20 17:01:57 | 3,081,307 0 | 3,081,307 | Form 13D |
6 | PFIZER INC Pfizer Ventures (US) LLC 10% Owner | 2022-02-11 19:01:39 | 2,340,330 0 | 2,340,330 | Form 13G |
7 | Renstrup Jens Chief Medical Officer | 2021-01-11 09:30:41 | 299,099 0 | 299,099 | Form 4 |
8 | Smith L. Mary Chief Development Officer | 2024-01-08 21:13:06 | 293,363 0 | 293,363 | Form 4 |
9 | Greco Michael V. General Counsel & Secretary | 2019-09-12 16:29:46 | 246,975 0 | 246,975 | Form 3 |
10 | Burgess Michael F. Head of Research & Development | 2022-07-20 18:02:22 | 49,584 0 | 49,584 | Form 4 |
11 | Edris Badreddin Chief Operating Officer | 2025-07-02 16:26:13 | 0 0 | 0 | Form 4 |
12 | PATRICK DEVAL L Director | 2019-09-12 16:36:08 | 0 0 | 0 | Form 3 |
13 | LYNCH DANIEL Director | 2025-07-02 16:25:44 | 0 0 | 0 | Form 4 |
14 | Lewis-Hall Freda C Director | 2025-07-02 16:25:19 | 0 0 | 0 | Form 4 |
15 | Hambleton Julie Director | 2025-07-02 16:24:48 | 0 0 | 0 | Form 4 |
16 | Fuhrman Alan Director | 2025-07-02 16:24:23 | 0 0 | 0 | Form 4 |
17 | Lin Tai-An Chief Scientific Officer | 2025-07-02 16:23:58 | 0 0 | 0 | Form 4 |
18 | Ashar Bhavesh Chief Commercial Officer | 2025-07-02 16:22:47 | 0 0 | 0 | Form 4 |
19 | Cassidy James Chief Medical Officer | 2025-07-02 16:21:57 | 0 0 | 0 | Form 4 |
20 | MACKAY MARTIN Director | 2025-07-02 16:21:32 | 0 0 | 0 | Form 4 |
21 | ALBAN CARLOS Director | 2025-07-02 16:21:04 | 0 0 | 0 | Form 4 |
22 | Nofi Michael Chief Accounting Officer | 2025-07-02 16:20:38 | 0 0 | 0 | Form 4 |
23 | Pichl Daniel Chief People Officer | 2025-07-02 16:19:20 | 0 0 | 0 | Form 4 |
24 | Perier Francis I Jr Chief Financial Officer | 2025-07-02 16:18:54 | 0 0 | 0 | Form 4 |
25 | Islam Saqib Chief Executive Officer | 2025-07-02 16:18:21 | 0 0 | 0 | Form 4 |
26 | Weinstein Herschel S General Counsel & Secretary | 2025-07-02 16:17:54 | 0 0 | 0 | Form 4 |